Recent posts

TypePostAuthorRepliesLast updated
Blog entryKite Pharma Uses CRADAs to Conduct Important Clinical Research on New Cancer Treatments Zack Struver031 weeks 1 day ago
Blog entry5 October 2016: Statement of Knowledge Ecology International at inaugural Marrakesh Treaty Assembly thiru032 weeks 5 days ago
Blog entryWIPO GA 2016: Statement by India on behalf of Asia Pacific Group - Report on the IGC thiru032 weeks 6 days ago
Blog entryWIPO General Assembly 2016: Statement of Knowledge Ecology International on the Report of the SCCR thiru033 weeks 13 hours ago
Blog entryWIPO General Assembly 2016: Opening Statement of Knowledge Ecology International KEI Staff033 weeks 1 day ago
Blog entryGeneral Assembly 2016 - Opening Statement of Bangladesh on behalf of the LDC Group thiru033 weeks 1 day ago
Blog entryDeciphering consultant speak: Romulus, a case study thiru033 weeks 2 days ago
Blog entryWIPO General Assembly 2016: Opening statement of Chile on behalf of the Group of Latin and the Caribbean Group (GRULAC) thiru033 weeks 2 days ago
Blog entrySCP24:WIPO patent committee adopts robust work program on patents and health, limitations and exceptions and quality of patents thiru034 weeks 16 hours ago
Blog entryUSPTO publishes new estimates of "IP-Intensive" industries, spin results James Love034 weeks 2 days ago
PageAndrew S. Goldman, Counsel, Policy and Legal Affairs Claire Cassedy034 weeks 2 days ago
Blog entryNational Association of Manufacturers told USTR the EU position on LDC extension made a mockery of international trading system thiru034 weeks 5 days ago
Blog entryDifferences between the march-in, royalty free right, and government use options James Love034 weeks 6 days ago
Blog entry500+ Pages of Documents on NFL Attempts to Influence NIH Funding of Concussion Studies Zack Struver035 weeks 1 day ago
Blog entryNIH Waivers for U.S. Manufacturing Requirements for Federally-Funded Drugs Zack Struver035 weeks 2 days ago
Blog entryKEI Statement on United Nations Secretary-General's High-Level Panel on Access to Medicines Report KEI Staff035 weeks 5 days ago
Blog entryCancer Moonshot Blue Ribbon Panel Does Not Address Pricing, Alternative Funding Models Zack Struver035 weeks 5 days ago
Blog entrySummary of Report of United Nations Secretary-General's High-Level Panel on Access to Medicines Zack Struver035 weeks 6 days ago
Blog entryTRIPS Council (October 2014): India calls for de-linkage and innovation inducement prizes at WTO discussions on IP & innovation thiru036 weeks 11 hours ago
Blog entryWIPO Marrakesh Treaty for the blind to come into force September 30, 2016, following ratification by Canada James Love036 weeks 5 days ago
Blog entryGerman Court Issues Compulsory License on HIV Drug Patent Andrew Goldman036 weeks 5 days ago
Blog entryCommentary on Hillary Clinton's Plan to Respond to Unjustified Price Hikes for Long-Available Drugs Claire Cassedy037 weeks 7 hours ago
Blog entryKEI Briefing Note 2016:2: 2015-2016 Pharmaceutical Transparency Legislation Zack Struver037 weeks 1 day ago
Book pagePublications and Research Notes James Love037 weeks 1 day ago
Blog entry2016: KEI/MSF comments to NIH on licensing of patents on Attenuated Respiratory Syncytial Virus (RSV) Vaccines James Love038 weeks 5 days ago